References

The effect of digoxin on mortality and morbidity in patients with heart failure

10.1056/nejm199702203360801 · 1997 · External reference

Digitoxin in patients with heart failure and reduced ejection fraction

10.1056/nejmoa2415471 · 2025 · External reference

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy

10.1093/eurheartj/ehaa183 · 2020 · External reference

Association of serum digoxin concentration and outcomes in patients with heart failure

10.1001/jama.289.7.871 · 2003 · External reference

Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction; a randomized controlled study

10.1038/s41591-026-04406-6 · 2026 · External reference

10.1001/jama.2026.7886

10.1001/jama.2026.7886 · 2026 · External reference

Consequences of discontinuing long-term drug treatment in patients with heart failure and reduced ejection fraction

10.1016/j.jacc.2024.09.005 · 2024 · External reference

Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure

10.1016/j.amjcard.2007.02.099 · 2007 · External reference

Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trial

10.1002/ejhf.3428 · 2024 · External reference

Heart failure patients with reduced or mildly reduced ejection fraction: baseline characteristics of the low-dose digoxin outcome DECISION trial

10.1093/ejhf/xuag073 · External reference

Semiparametric regression for the mean and rate functions of recurrent events

10.1111/1467-9868.00259 · 2000 · External reference

Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry

10.1093/ehjcvp/pvab079 · 2022 · External reference

Blinded withdrawal of long-term randomized treatment with empagliflozin or placebo in patients with heart failure

10.1161/circulationaha.123.065748 · 2023 · External reference

Blinded withdrawal of finerenone after long-term treatment in the FINEARTS-HF trial

10.1016/j.jacc.2025.05.038 · 2025 · External reference

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial

10.1016/s0140-6736(18)32484-x · 2019 · External reference

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors

10.1056/nejm199307013290101 · 1993 · External reference

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

10.1016/0735-1097(93)90403-n · 1993 · External reference

Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?

10.1016/j.jacc.2003.07.020 · 2003 · External reference

Digoxin. A neurohormonal modulator in heart failure?

10.1161/01.cir.84.5.2181 · 1991 · External reference

Double-blind placebo-controlled study of ibopamine and diagoxin in patients with mild to moderate heart failure: results of the Dutch of the Ibopamine Multicenter Trial (DIMT)

10.1016/0735-1097(93)90579-p · 1993 · External reference

Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine

10.1016/0735-1097(95)00285-3 · 1995 · External reference